Periodontal and Systemic Diseases: Shared Pathophysiology

Trends in Immunotherapy

Review Article

Periodontal and Systemic Diseases: Shared Pathophysiology

Downloads

https://doi.org/10.54963/ti.v9i4.1408
Najafimakhsoos, N., & Cesari, C. (2025). Periodontal and Systemic Diseases: Shared Pathophysiology. Trends in Immunotherapy, 9(4), 146–159. https://doi.org/10.54963/ti.v9i4.1408
Volume 9 Issue 4 (December 2025): In Progress
Copyright (c) 2025 Neda Najafimakhsoos, Claudio Cesari
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

License

Trends in Immunotherapy (TI)  publishes accepted manuscripts under Creative Commons Attribution 4.0 International (CC BY 4.0). Authors who submit their papers for publication by TI agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source are properly cited, anyone may copy, redistribute, reuse, and transform the content.

Authors

  • Neda Najafimakhsoos

    Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Via San Vitale 59, 40125 Bologna BO, Italy
  • Claudio Cesari

    Periodontal Unit, Department of Dentistry, Vita-Salute San Raffaele University, Universtiy of Milan, Via Olgettina 58, 20132 Milan MI, Italy

Received: 15 July 2025; Revised: 21 July 2025; Accepted: 4 August 2025; Published: 14 November 2025

Periodontitis is a chronic, progressive inflammatory disease characterized by the gradual destruction of the supporting structures of the teeth, including the periodontal ligament and alveolar bone. This condition primarily originates from microbial dysbiosis in the oral cavity, further influenced by the host’s immune responses and a variety of environmental and behavioral factors. As the leading cause of tooth loss and edentulism among adults, periodontitis also has far-reaching systemic consequences. An expanding body of scientific evidence has established strong associations between periodontitis and numerous systemic conditions, including cardiovascular disease, diabetes mellitus, respiratory disorders, thyroid dysfunction, and obstructive sleep apnea (OSA). This review examines the potential biological and clinical connections between periodontitis and these systemic diseases by first providing an overview of the normal physiological functions and pathological changes of each condition. It then explores the shared immunological and pathophysiological pathways, with particular focus on inflammatory mediators, immune system dysregulation, and microbial translocation. By integrating perspectives from disciplines such as microbiology, immunology, and clinical research, this review underscores the integral role of oral health in systemic well-being. It also highlights the necessity of early detection, interdisciplinary cooperation, and preventive strategies—including lifestyle modifications—to manage common risk factors and improve comprehensive patient outcomes.

References

  1. Di Stefano, M.; Polizzi, A.; Santonocito, S.; et al. Impact of Oral Microbiome in Periodontal Health and Periodontitis: A Critical Review on Prevention and Treatment. Int. J. Mol. Sci. 2022, 23, 5142.
  2. Socransky, S.S.; Haffajee, A.D. Periodontal Microbial Ecology. Periodontol. 2000 2005, 38, 135–187.
  3. Cui, Z.; Wang, P.; Gao, W. Microbial Dysbiosis in Periodontitis and Peri-Implantitis: Pathogenesis, Immune Responses, and Therapeutic. Front. Cell. Infect. Microbiol. 2025, 15, 1517154.
  4. Dehkordi, S. The Impact of Periodontal Disease on Systemic Health: A Comprehensive Review. J. Oral Dent. Health Nexus 2024, 1, 18–28.
  5. Cugini, C.; Shanmugam, M.; Landge, N.; et al. The Role of Exopolysaccharides in Oral Biofilms. J. Dent. Res. 2019, 98, 739–745.
  6. Maruyama, N.; Maruyama, F.; Takeuchi, Y.; et al. Intraindividual Variation in Core Microbiota in Peri-Implantitis and Periodontitis. Sci. Rep. 2014, 4, 6602.
  7. Jung, H.J.; Lee, W. Difference in Microbiome Compositions of Healthy Peri-Implant Sulcus and Peri-Implantitis Sulcus From the Same Patient. Heliyon 2023, 9, e20303.
  8. Scannapieco, F.A.; Dongari-Bagtzoglou, A. Dysbiosis Revisited: Understanding the Role of the Oral Microbiome in the Pathogenesis of Gingivitis and Periodontitis: A Critical Assessment. J. Periodontol. 2021, 92, 1071–1078.
  9. Van Dyke, T.E.; Bartold, P.M.; Reynolds, E.C. The Nexus Between Periodontal Inflammation and Dysbiosis. Front. Immunol. 2020, 11, 511.
  10. Huang, C.; Shi, G. Smoking and Microbiome in Oral, Airway, Gut and Some Systemic Diseases. J. Transl. Med. 2019, 17, 225.
  11. Leite, F.R.M.; Nascimento, G.G.; Scheutz, F.; et al. Effect of Smoking on Periodontitis: A Systematic Review and Meta-Regression. Am. J. Prev. Med. 2018, 54, 831–841.
  12. Benahmed, A.G.; Mujawdiya, P.K.; Noor, S.; et al. Porphyromonas gingivalis in the Development of Periodontitis: Impact on Dysbiosis and Inflammation. Arch. Razi Inst. 2022, 77, 1539–1551.
  13. Zheng, S.; Yu, S.; Fan, X.; et al. Porphyromonas gingivalis Survival Skills: Immune Evasion. J. Periodontal Res. 2021, 56, 1007–1018.
  14. Xu, W.; Zhou, W.; Wang, H.; et al. Roles of Porphyromonas gingivalis and Its Virulence Factors in Periodontitis. Adv. Protein Chem. Struct. Biol. 2020, 120, 45–84.
  15. Pani, P.; Tsilioni, I.; McGlennen, R.; et al. IL-1B(3954) Polymorphism and Red Complex Bacteria Increase IL-1b (GCF) Levels in Periodontitis. J. Periodontal Res. 2021, 56, 501–511.
  16. Huang, X.; Xie, M.; Xie, Y.; et al. The Roles of Osteocytes in Alveolar Bone Destruction in Periodontitis. J. Transl. Med. 2020, 18, 479.
  17. Rao, A.; Kumar, B.K. Role of Periodontal Pathogens in Atherosclerotic Plaque Development and Progression: An Overview. Acta Microbiol. Immunol. Hung. 2023, 70, 272–277.
  18. Huang, X.; Xie, M.; Lu, X.; et al. The Roles of Periodontal Bacteria in Atherosclerosis. Int. J. Mol. Sci. 2023, 24, 12861.
  19. Kumar, R.; Dhanasekaran, A.; Venugopal, P. A Narrative Review on Bridging the Gap Between Periodontitis and Cardiovascular Disease: Exploring the Cellular and Molecular Mechanisms of Periodontitis-Driven Atherosclerosis. Mol. Biol. Rep. 2025, 52, 690.
  20. Bale, B.F.; Doneen, A.L.; Vigerust, D.J. High-Risk Periodontal Pathogens Contribute to the Pathogenesis of Atherosclerosis. Postgrad. Med. J. 2017, 93, 215–220.
  21. Galkina, E.; Ley, K. Vascular Adhesion Molecules in Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2292–2301.
  22. Mann, D.L. The Emerging Role of Innate Immunity in the Heart and Vascular System: For Whom the Cell Tolls. Circ. Res. 2011, 108, 1133–1145.
  23. Dietmann, A.; Millonig, A.; Combes, V.; et al. Effects of Aggregatibacter actinomycetemcomitans Leukotoxin on Endothelial Cells. Microb. Pathog. 2013, 61–62, 43–50.
  24. Gaetti-Jardim, E.; Marcelino, S.L.; Feitosa, A.C.; et al. Quantitative Detection of Periodontopathic Bacteria in Atherosclerotic Plaques from Coronary Arteries. J. Med. Microbiol. 2009, 58, 1568–1575.
  25. Figuero, E.; Sánchez-Beltrán, M.; Cuesta-Frechoso, S.; et al. Detection of Periodontal Bacteria in Atheromatous Plaque by Nested Polymerase Chain Reaction. J. Periodontol. 2011, 82, 1469–1477.
  26. Cowan, L.T.; Lakshminarayan, K.; Lutsey, P.L.; et al. Periodontal Disease and Incident Venous Thromboembolism: The Atherosclerosis Risk in Communities Study. J. Clin. Periodontol. 2019, 46, 12–19.
  27. Nishimura, R.A.; Otto, C.M.; Bonow, R.O.; et al. 2017 AHA/ACC Focused Update of 2014 AHA/ACC Guideline for the Management of Patient with Heart Disease: A Report of American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideline. Circulation 2017, 135, e1159–e1195
  28. Isola, G.; Polizzi, A. Editorial: Periodontitis and Cardiovascular Disease: Shared Clinical Challenges in Patient Care. Front. Dent. Med. 2025, 6, 1613091.
  29. Rahim, A.; Hassan, S.; Ullah, N.; et al. Association and Comparison of Periodontal and Oral Hygiene Status with Serum HbA1c Levels: A Cross-Sectional Study. BMC Oral Health 2023, 23, 442.
  30. Das, A.C.; Das, S.J.; Panda, S.; et al. Adjunctive Effect of Doxycycline with Conventional Periodontal Therapy on Glycemic Level for Chronic Periodontitis with Type 2 Diabetes Mellitus Subjects. J. Contemp. Dent. Pract. 2019, 20, 1417–1423.
  31. Kidambi, S.; Patel, S.B. Diabetes Mellitus: Considerations for Dentistry. J. Am. Dent. Assoc. 2008, 139, 8S–18S.
  32. Freeman, V.S. Glucose and Hemoglobin A1c. Lab. Med. 2014, 45, e21–e24.
  33. Mirnic, J.; Djuric, M.; Brkic, S.; et al. Pathogenic Mechanisms That May Link Periodontal Disease and Type 2 Diabetes Mellitus—The Role of Oxidative Stress. Int. J. Mol. Sci. 2024, 25, 9806.
  34. Karima, M.; Kantarci, A.; Ohira, T.; et al. Enhanced Superoxide Release and Elevated Protein Kinase C Activity in Neutrophils from Diabetic Patients: Association with Periodontitis. J. Leukoc. Biol. 2005, 78, 862–870.
  35. Sonoki, K.; Nakashima, S.; Takata, Y.; et al. Decreased Lipid Peroxidation Following Periodontal Therapy in Type 2 Diabetic Patients. J. Periodontol. 2006, 77, 1907–1913.
  36. Allen, E.M.; Matthews, J.B.; O’Halloran, D.J.; et al. Oxidative and Inflammatory Status in Type 2 Diabetes Patients with Periodontitis. J. Clin. Periodontol. 2011, 38, 894–901.
  37. Abiko, Y.; Selimovic, D. The Mechanism of Protracted Wound Healing on Oral Mucosa in Diabetes: Review. Bosn. J. Basic Med. Sci. 2010, 10, 186–191.
  38. Lin, D.; Takemoto, D.J. Oxidative Activation of Protein Kinase Cγ Through the C1 Domain: Effects on Gap Junctions. J. Biol. Chem. 2005, 280, 13682–13693.
  39. Polak, D.; Sanui, T.; Nishimura, F.; et al. Diabetes as a Risk Factor for Periodontal Disease—Plausible Mechanisms. Periodontol. 2000 2020, 83, 46–58.
  40. Miyata, T.; Kawai, R.; Taketomi, S.; et al. Possible Involvement of Advanced Glycation End-Products in Bone Resorption. Nephrol. Dial. Transplant. 1996, 11, 54–57.
  41. Aemaimanan, P.; Amimanan, P.; Taweechaisupapong, S. Quantification of Key Periodontal Pathogens in Insulin-Dependent Type 2 Diabetic and Non-Diabetic Patients with Generalized Chronic Periodontitis. Anaerobe 2013, 22, 64–68.
  42. Santos, V.R.; Ribeiro, F.V.; Lima, J.A.; et al. Cytokine Levels in Sites of Chronic Periodontitis of Poorly Controlled and Well-Controlled Type 2 Diabetic Subjects. J. Clin. Periodontol. 2010, 37, 1049–1058.
  43. Jiang, S.Y.; Wei, C.C.; Shang, T.T.; et al. High Glucose Induces Inflammatory Cytokine Through Protein Kinase C-Induced Toll-Like Receptor 2 Pathway in Gingival Fibroblasts. Biochem. Biophys. Res. Commun. 2012, 427, 666–670.
  44. Fischer, T.W.; Slominski, A.; Zmijewski, M.A.; et al. Melatonin as a Major Skin Protectant: From Free Radical Scavenging to DNA Damage Repair. Exp. Dermatol. 2008, 17, 713–730.
  45. Cutando, A.; Gómez-Moreno, G.; Villalba, J.; et al. Relationship between Salivary Melatonin Levels and Periodontal Status in Diabetic Patients. J. Pineal Res. 2003, 35, 239–244.
  46. Taylor, J.J.; Preshaw, P.M.; Lalla, E. A Review of the Evidence for Pathogenic Mechanisms That May Link Periodontitis and Diabetes. J. Clin. Periodontol. 2013, 40, S113–S134.
  47. Su, Y.; Ye, L.; Hu, C.; et alL. Periodontitis as a Promoting Factor of T2D: Current Evidence and Mechanisms. Int. J. Oral Sci. 2023, 15, 25.
  48. Larsson, L.; Castilho, R.M.; Giannobile, W.V. Epigenetics and Its Role in Periodontal Diseases: A State-of-the-Art Review. J. Periodontol. 2015, 86, 556–568.
  49. Wu, X.; Zhang, Y. TET-Mediated Active DNA Demethylation: Mechanism, Function and Beyond. Nat. Rev. Genet. 2017, 18, 517–534.
  50. Yin, X.; Xu, Y. Structure and Function of TET Enzymes. Adv. Exp. Med. Biol. 2016, 945, 275–302.
  51. Du, Y.; Xiao, H.; Luo, R.; et al. The Role of HbA1c in the Bidirectional Relationship between Periodontitis and Diabetes and Related Interventions: A Narrative Review. Front. Nutr. 2025, 12, 1606223.
  52. Khouly, I.; Braun, R.S.; Ordway, M.; et al. The Role of DNA Methylation and Histone Modification in Periodontal Disease: A Systematic Review. Int. J. Mol. Sci. 2020, 21, 217.
  53. Asa'ad, F.; Petrenya, N.; Jönsson, B.; et al. Polymorphism in Epigenetic Regulating Genes in Relation to Periodontitis, Number of Teeth, and Levels of High-Sensitivity C-Reactive Protein and Glycated Hemoglobin: The Tromsø Study 2015–2016. J. Periodontol. 2023, 94, 1324–1337.
  54. Fu, L.; Guerrero, C.R.; Zhong, N.; et al. TET-Mediated Formation of 5-Hydroxymethylcytosine in RNA. J. Am. Chem. Soc. 2014, 136, 11582–11585.
  55. Rodrigues, S.O.; Cunha, C.M.C.D.; Soares, G.M.V.; et al. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease. Pharmaceuticals 2021, 14, 979.
  56. Wu, D.; Hu, D.; Chen, H.; et al. Glucose-Regulated Phosphorylation of TET2 by AMPK Reveals a Pathway Linking Diabetes to Cancer. Nature 2018, 559, 637–641.
  57. World Health Organization. Chronic obstructive pulmonary disease (COPD). Available online: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) (accessed on 16 August, 2025)
  58. Barnes, P.J. The Cytokine Network in Asthma and Chronic Obstructive Pulmonary Disease. J. Clin. Invest. 2008, 118, 3546–3556.
  59. Rastogi, T.; Chowdhary, Z.; Krishna, M.K.; et al. Prevalence of Periodontitis in Patients with Pulmonary Disease: A Cross-Sectional Survey in the Industrial District of India. J. Indian Soc. Periodontol. 2019, 23, 269–274.
  60. Zhang, Z.; Wen, S.; Liu, J.; et al. Advances in the Relationship between Periodontopathogens and Respiratory Diseases (Review). Mol. Med. Rep. 2024, 29, 42.
  61. Chung, J.H.; Hwang, H.J.; Kim, S.H.; et al. Associations between Periodontitis and Chronic Obstructive Pulmonary Disease: The 2010 to 2012 Korean National Health and Nutrition Examination Survey. J. Periodontol. 2016, 87, 864–871.
  62. Gomes-Filho, I.S.; Soledade-Marques, K.R.; Seixas da Cruz, S.; et al. Does Periodontal Infection Have an Effect on Severe Asthma in Adults? J. Periodontol. 2014, 85, e179–e187.
  63. Soledade-Marques, K.R.; Gomes-Filho, I.S.; da Cruz, S.S.; et al. Association between Periodontitis and Severe Asthma in Adults: A Case-Control Study. Oral Dis. 2018, 24, 442–448.
  64. Ferreira, M.K.M.; Ferreira, R.O.; Castro, M.M.L.; et al. Is There an Association between Asthma and Periodontal Disease among Adults? Systematic Review and Meta-Analysis. Life Sci. 2019, 223, 74–87.
  65. Han, E.R.; Choi, I.S.; Kim, H.K.; et al. Inhaled Corticosteroid-Related Tooth Problems in Asthmatics. J. Asthma 2009, 46, 160–164.
  66. Gani, F.; Caminati, M.; Bellavia, F.; et al. Oral Health in Asthmatic Patients: A Review: Asthma and Its Therapy May Impact on Oral Health. Clin. Mol. Allergy 2020, 18, 22.
  67. Tan, L.; Wang, H.; Li, C.; et al. 16S rDNA-Based Metagenomic Analysis of Dental Plaque and Lung Bacteria in Patients with Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease. J. Periodontal Res. 2014, 49, 760–769.
  68. Yamasaki, K.; Kawanami, T.; Yatera, K.; et al. Significance of Anaerobes and Oral Bacteria in Community-Acquired Pneumonia. PLoS One 2013, 8, e63103.
  69. Nagaoka, K.; Yanagihara, K.; Morinaga, Y.; et al. Detection of Fusobacterium nucleatum in Two Cases of Empyema and Lung Abscess Using Paromomycin–Vancomycin Supplemented Brucella HK Agar. Anaerobe 2017, 43, 99–101.
  70. Homsi, N.; Kapila, R. Aggregatibacter actinomycetemcomitans Causing Empyema Necessitans and Pyomyositis in an Immunocompetent Patient. Cureus 2020, 12, e9454.
  71. Card, J.W.; Carey, M.A.; Voltz, J.W.; et al. Modulation of Allergic Airway Inflammation by the Oral Pathogen Porphyromonas gingivalis. Infect. Immun. 2010, 78, 2488–2496.
  72. He, Y.; Shiotsu, N.; Uchida-Fukuhara, Y.; et al. Outer Membrane Vesicles Derived from Porphyromonas gingivalis Induced Cell Death with Disruption of Tight Junctions in Human Lung Epithelial Cells. Arch. Oral Biol. 2020, 118, 104841.
  73. Bunte, K.; Beikler, T. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases. Int. J. Mol. Sci. 2019, 20, 3394.
  74. Thomas, R.; Qiao, S.; Yang, X. Th17/Treg Imbalance: Implications in Lung Inflammatory Diseases. Int. J. Mol. Sci. 2023, 24, 4865.
  75. Ortarzewska, M.; Nijakowski, K.; Kolasińska, J.; et al. Salivary Alterations in Autoimmune Thyroid Diseases: A Systematic Review. Int. J. Environ. Res. Public Health 2023, 20, 4849.
  76. Attard, N.J.; Zarb, G.A. A Study of Dental Implants in Medically Treated Hypothyroid Patients. Clin. Implant Dent. Relat. Res. 2002, 4, 220–231.
  77. Kozma, A.; Teodorescu, M.I.; Constantin, A.T.; et al. Dento-Maxillary Changes in Children with Congenital Hypothyroidism: Mini Review and Clinical Cases. Rom. J. Leg. Med. 2019, 27, 382–387.
  78. Ortarzewska, M.; Nijakowski, K.; Jankowski, J.; et al. Periodontal Disease in Patients with Thyroid Diseases: A Systematic Review with Meta-Analysis. Adv. Med. Sci. 2024, 69, 289–295.
  79. Medara, N.; Lenzo, J.C.; Walsh, K.A.; et al. A Review of T Helper 17 Cell-Related Cytokines in Serum and Saliva in Periodontitis. Cytokine 2021, 138, 155340.
  80. Antonelli, A.; Ferrari, S.M.; Corrado, A.; et al. Autoimmune Thyroid Disorders. Autoimmun. Rev. 2015, 14, 174–180.
  81. Ferrari, S.M.; Ruffilli, I.; Elia, G.; et al. Chemokines in Hyperthyroidism. J. Clin. Transl. Endocrinol. 2019, 16, 100196.
  82. Khan, F.A.; Al-Jameil, N.; Khan, M.F.; et al. Thyroid Dysfunction: An Autoimmune Aspect. Int. J. Clin. Exp. Med. 2015, 8, 6677–6681.
  83. Song, E.; Park, M.J.; Kim, J.A.; et al. Implication of Thyroid Function in Periodontitis: A Nationwide Population-Based Study. Sci. Rep. 2021, 11, 22127.
  84. Bhankhar, R.R.; Hungund, S.; Kambalyal, P.; et al. Effect of Nonsurgical Periodontal Therapy on Thyroid Stimulating Hormone in Hypothyroid Patients with Periodontal Diseases. Indian J. Dent. Res. 2017, 28, 16–21.
  85. Chen, S.H.; Chen, J.F.; Hung, Y.T.; et al. Exploring the Relationship between Periodontitis, Anti-Periodontitis Therapy, and Extra-Oral Cancer Risk: Findings from a Nationwide Population-Based Study. Biomedicines 2023, 11, 1949.
  86. Gao, Y.; Huang, D.; Liu, Y.; et al. Periodontitis and Thyroid Function: A Bidirectional Mendelian Randomization Study. J. Periodontal Res. 2024, 59, 491–499.
  87. Kwon, M.; Jeong, Y.J.; Kwak, J.; et al. Association between Oral Health and Thyroid Disorders: A Population-Based Cross-Sectional Study. Oral Dis. 2022, 28, 2277–2284.
  88. Aldulaijan, H.A.; Cohen, R.E.; Stellrecht, E.M.; et al. Relationship between Hypothyroidism and Periodontitis: A Scoping Review. Clin. Exp. Dent. Res. 2020, 6, 147–157.
  89. Zeng, Y.; Deng, J.J.; Jiang, Q.L.; et al. Thyrotropin Inhibits Osteogenic Differentiation of Human Periodontal Ligament Stem Cells. J. Periodontal Res. 2023, 58, 668–678.
  90. Hotokezaka, H.; Hayashida, H.; Ohara, N.; et al. Cloning and Sequencing of the groESL Homologue from Porphyromonas gingivalis. Biochim. Biophys. Acta 1994, 1219, 175–178.
  91. Gammazza, A.M.; Rizzo, M.; Citarrella, R.; et al. Elevated Blood Hsp60, Its Structural Similarities and Cross-Reactivity with Thyroid Molecules, and Its Presence on the Plasma Membrane of Oncocytes Point to the Chaperonin as an Immunopathogenic Factor in Hashimoto's Thyroiditis. Cell Stress Chaperones 2014, 19, 343–353.
  92. Feitosa, D.S.; Marques, M.R.; Casati, M.Z.; et al. The Influence of Thyroid Hormones on Periodontitis-Related Bone Loss and Tooth-Supporting Alveolar Bone: A Histological Study in Rats. J. Periodontal Res. 2009, 44, 472–478.
  93. Shcherba, V.; Krynytska, I.; Marushchak, M.; et al. Does Thyroid Dysfunction Influence Inflammatory Mediators in Experimental Periodontitis? Endocr. Regul. 2021, 55, 131–141.
  94. American Sleep Apnea Society. Available online: https://sleepapneasociety.org/sleep-apnea (accessed on 16 August 2025)
  95. Parenti, S.I.; Cesari, C.; Godenza, V.D.; et al. Periodontal Disease and Obstructive Sleep Apnea: Shared Mechanisms, Clinical Implications, and Future Research Directions. Appl. Sci. 2025, 15, 542.
  96. Meliante, P.G.; Zoccali, F.; Cascone, F.; et al. Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea. Int. J. Mol. Sci. 2023, 24, 5478.
  97. Carra, M.C.; Balagny, P.; Bouchard, P. Sleep and Periodontal Health. Periodontol. 2000 2024, 96, 42–73.
  98. Al-Jewair, T.S.; Al-Jasser, R.; Almas, K. Periodontitis and Obstructive Sleep Apnea’s Bidirectional Relationship: A Systematic Review and Meta-Analysis. Sleep Breath. 2015, 19, 1111–1120.
  99. Bianchi, G.; De’angelis, N.; Gavriilidis, P.; et al. Oral Microbiota in Obstructive Sleep Apnea Patients: A Systematic Review. Sleep Breath. 2023, 27, 1203–1216.
  100. Corral, M.A.T.; Daza, E.H.; Jimenez, H.K.C.; et al. Cryptic Oral Microbiota: What Is Its Role as Obstructive Sleep Apnea-Related Periodontal Pathogens? Int. J. Environ. Res. Public Health 2023, 20, 1740.
  101. Keller, J.J.; Wu, C.S.; Chen, Y.H.; et al. Association between Obstructive Sleep Apnoea and Chronic Periodontitis: A Population-Based Study. J. Clin. Periodontol. 2013, 40, 111–117.

Copyright © UK Scientific Publishing Limited.